Diflucan powder for oral suspension (10 mg/ml and 40 mg/ml) - amended labels and patient information leaflet

New feature! Try PharmData's Temporary Safeguarding Payments service to help identify if your pharmacy is eligible to make a claim. Over 500 pharmacies have made successful claims under the NHSBSA scheme, averaging more than £200 per pharmacy per month. Try now for free »

Diflucan powder for oral suspension (10 mg/ml and 40 mg/ml) - amended labels and patient information leaflet

2014-12-17 14:58:04 (7 year(s) ago)

Summary

(Pfizer Limited) Clarification of confusion resulting from amended labels and patient information leaflet – class 4 caution in use. (EL (12)A/31)

Read full MHRA article

Respond to this alert